| Company/Division name | Bayer |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 3000 |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2017 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 8000 |
| Country(ies) from which reshored: | Germany |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Social/ethical concerns |
